Skip to main content
Equibles
CGON logo

CGON · CG Oncology, Inc. · Short Interest

Track CGON — free

Use CGON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CGON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$68.71 +1.33 (+1.97%)
Russell 2000 member Rebalance outlook locked
Market Cap
$6.24B
Shares
88.64M
Volume · Oct 5 788.39K Avg daily vol (3M) 898.25K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

CGON Latest Reported Short Interest

FINRA reported 11,254,500 CGON shares sold short as of the September 15, 2026 settlement date, a decrease of 141,656 shares. Days to cover was 17.01 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CGON Short Interest Forecast

Equibles' model estimates 11,258,846 shares sold short for the September 30, 2026 settlement, +0.0% versus the latest reported position, with a likely range of 10,015,951 to 12,390,293 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 Low confidence 54% chance it falls
11,258,846 +0.0% vs reported
Likely range 10,015,951 to 12,390,293 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
67/100
Short interest 12.7% of shares — P93 Days to cover 17.0 — P95 Price vs VWAP -7.7% — P40 Short-volume trend -16.2% — P8 Short interest change -1.2% — P38 Worst FTD 0.15% of shares — P88

Positioning score 66.7 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-05 21:50 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 Scheduled
    FINRA publishes Oct 9
    		 — — — —
    2026-09-15 11,254,500 11,396,156 -141,656 17.01
    2026-08-31 11,396,156 11,248,462 +147,694 16.07
    2026-08-14 11,248,462 11,844,115 -595,653 14.85
    2026-07-31 11,844,115 12,105,610 -261,495 13.53
    2026-07-15 12,105,610 12,068,774 +36,836 12.24
    2026-06-30 12,068,774 10,559,078 +1,509,696 7.61
    2026-06-15 10,559,078 9,810,951 +748,127 11.61
    2026-05-29 9,810,951 9,179,394 +631,557 10.15
    2026-05-15 9,179,394 9,222,491 -43,097 10.00
    2026-04-30 9,222,491 9,534,138 -311,647 10.13
    2026-04-15 9,534,138 10,536,784 -1,002,646 7.60
    2026-03-31 10,536,784 10,554,681 -17,897 6.87
    2026-03-13 10,554,681 9,293,407 +1,261,274 6.35
    2026-02-27 9,293,407 9,496,710 -203,303 13.14
    2026-02-13 9,496,710 9,242,783 +253,927 11.14
    2026-01-30 9,242,783 9,387,150 -144,367 7.08
    2026-01-15 9,387,150 12,919,357 -3,532,207 5.59
    2025-12-31 12,919,357 13,145,322 -225,965 14.45
    2025-12-15 13,145,322 13,713,699 -568,377 17.44
    2025-11-28 13,713,699 13,205,390 +508,309 17.17
    2025-11-14 13,205,390 12,477,457 +727,933 14.03
    2025-10-31 12,477,457 12,222,593 +254,864 14.84
    2025-10-15 12,222,593 11,991,344 +231,249 10.73

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1991792 CUSIP 156944100 13F (30d) 6 filings 6 filers Visit website Investor relations